Study guide

2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns

UEMS European Board of Dermatovenereology Diploma Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Eligibility & Examination Regulations

1.1 EBDVD Exam Format, Session Timing & Scoring Rules 1.2 Eligibility Routes, Application Requirements & Re-take Regulations 1.3 UEMS-EBDV Governance, European Training Requirements & Diploma Recognition

2 Chapter 2: Dermatologic Terminology, Lesion Morphology & Skin Biology

2.1 Skin Anatomy, Epidermal Biology & Barrier Function 2.2 Primary & Secondary Lesion Morphology 2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns

3 Chapter 3: Dermatopathology & Diagnostic Procedures

3.1 Biopsy Selection, Processing & Special Staining Techniques 3.2 Major Histopathologic Patterns & Tissue Reaction Types 3.3 Direct & Indirect Immunofluorescence Microscopy

4 Chapter 4: Epidemiology, Photobiology & Occupational Dermatology

4.1 Epidemiological Principles & Cutaneous Disease Burden 4.2 Photobiology & Photoprotection 4.3 Occupational Dermatoses & Contact Sensitisation Surveillance

5 Chapter 5: Papulosquamous, Follicular & Adnexal Disease

5.1 Psoriasis: Variants, Psoriatic Arthritis, Comorbidity & European Management 5.2 Lichen Planus, Lichenoid Eruptions & Other Papulosquamous Disorders 5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis 5.4 Hidradenitis Suppurativa, Hyperhidrosis & Other Sweat Gland Disorders

6 Chapter 6: Hair, Nails & Pigmentary Disorders

6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism 6.2 Nail Disorders, Onychomycosis & Nail Unit Tumours 6.3 Pigmentary Disorders: Vitiligo, Melasma & Other Hypo- and Hyperpigmentation

7 Chapter 7: Drug Reactions, Granulomatous & Deposition Disease and Skin Signs of Systemic Disease

7.1 Cutaneous Adverse Drug Reactions, SCARs & Dermatological Emergencies 7.2 Granulomatous & Deposition Disorders and Panniculitis 7.3 Skin Signs of Systemic Disease, Porphyrias, Nutritional Deficiency & Paraneoplastic Dermatoses

8 Chapter 8: Pruritus, Pregnancy & Geriatric Dermatology, Physical Injury and Mucosal Disease

8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology 8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing 8.3 Oral Mucosal, Lip, Genital Mucosal & Perianal (Proctological) Disease

9 Chapter 9: Autoimmune Bullous Diseases

9.1 Pemphigus Group: Pemphigus Vulgaris, Foliaceus & Paraneoplastic Pemphigus 9.2 Pemphigoid Group & Epidermolysis Bullosa Acquisita 9.3 Dermatitis Herpetiformis & Linear IgA Bullous Dermatosis

10 Chapter 10: Eczematous Disorders, Urticaria & Allergology

10.1 Atopic Dermatitis: Pathogenesis, Phenotypes & European Management 10.2 Allergic & Irritant Contact Dermatitis: Pathogenesis, Investigation & Common Allergens 10.3 Urticaria, Angioedema & Cutaneous Mastocytosis 10.4 Immediate-Type Allergy: Diagnostics, Anaphylaxis, Food, Venom & Drug Allergy

11 Chapter 11: Connective Tissue Diseases & Cutaneous Vasculitis

11.1 Cutaneous Lupus Erythematosus Spectrum & Systemic Manifestations 11.2 Dermatomyositis, Systemic Sclerosis & Scleroderma Spectrum 11.3 Cutaneous Vasculitis & Neutrophilic Dermatoses

12 Chapter 12: Paediatric & Genetic Dermatology

12.1 Vascular Anomalies & Benign Neonatal Dermatoses 12.2 Hereditary Ichthyoses & Disorders of Keratinisation 12.3 Genodermatoses, Neurocutaneous Syndromes & Epidermolysis Bullosa

13 Chapter 13: Bacterial, Mycobacterial, Parasitic & Zoonotic Cutaneous Infections

13.1 Bacterial Skin & Soft Tissue Infections 13.2 Mycobacterial Infections: Cutaneous Tuberculosis, Leprosy & Atypical Mycobacteria 13.3 Parasitic Infestations, Arthropod Bites & Cutaneous Leishmaniasis 13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections

14 Chapter 14: Viral & Fungal Cutaneous Infections

14.1 Herpesviridae Infections: HSV, VZV & HHV-8 14.2 Poxviruses & Human Papillomavirus Manifestations 14.3 Superficial, Subcutaneous & Deep Mycoses

15 Chapter 15: Sexually Transmitted Infections & Genital Infections

15.1 Syphilis: Pathogenesis, Clinical Stages, Serology & European Management 15.2 Neisseria gonorrhoeae, Chlamydia trachomatis & Genital Ulcer Diseases 15.3 HIV-Related Dermatoses, Partner Notification & Anogenital Lichen Sclerosus 15.4 Non-Gonococcal Urethritis, Mycoplasma genitalium, Trichomoniasis, Vaginal Infections & Balanitis

16 Chapter 16: Sexual Health Services, HIV Prevention & Anogenital Medicine

16.1 STI Epidemiology, Prevention, Services, Sexual History, HIV Testing, ART & PrEP/PEP 16.2 HPV-Related Anogenital Neoplasia, Cervical Screening & Common Gynaecological and Andrological Disorders 16.3 STIs in Pregnancy, Neonates & Children, Contraception, Sexual Health & Psychosexual Problems

17 Chapter 17: Keratinocyte Carcinomas, Precancerous Lesions & Other Skin Tumours

17.1 Actinic Keratoses, Bowen Disease & Field Cancerisation 17.2 Basal Cell Carcinoma: Subtypes, Risk Stratification & Management 17.3 Cutaneous Squamous Cell Carcinoma & Keratoacanthoma 17.4 Benign & Malignant Epidermal, Adnexal, Mesenchymal and Vascular Tumours, Cysts, Histiocytoses & Metastases

18 Chapter 18: Melanocytic Naevi & Melanoma

18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi 18.2 Melanoma Risk Factors, Clinical Presentation & Biopsy Protocol 18.3 Melanoma Histopathology, Breslow Thickness & Staging 18.4 Systemic Therapy for Advanced & Metastatic Melanoma

19 Chapter 19: Dermoscopy, Skin Imaging & Cutaneous Lymphomas

19.1 Dermoscopic Principles, Structures & Algorithmic Approaches 19.2 Dermoscopy of Non-Melanocytic Cutaneous Neoplasms 19.3 Non-Invasive Skin Imaging, Skin Function Measurement, Teledermatology & Skin Cancer Surveillance 19.4 Cutaneous Lymphomas, Merkel Cell Carcinoma & Cutaneous Sarcomas

20 Chapter 20: Dermatopharmacology, Systemic Therapeutics & Prescribing

20.1 Topical Corticosteroids, Calcineurin Inhibitors & Retinoids 20.2 Systemic Immunosuppressive & Biologic Therapies 20.3 Oral Retinoids & Phototherapy Modalities 20.4 Dermatological Prescribing: Anti-Infectives, Antihistamines, Antimalarials, Dapsone, Special Populations & Cutaneous Toxicity of Cancer Therapy

21 Chapter 21: Dermatosurgery, Cryotherapy, Lasers & Aesthetic Procedures

21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles 21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications 21.3 Cryosurgery, Electrosurgery & Cutaneous Lasers 21.4 Aesthetic & Corrective Dermatology, Photodynamic Therapy & Dermatological Radiotherapy

22 Chapter 22: Phlebology, Angiology, Psychodermatology & EBDVD Revision

22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers 22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema 22.3 Psychodermatology, Delusional Infestation & Factitious Disorders 22.4 EBDVD Revision Strategy & Cross-Topic Review

2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns

Key Takeaways Explain This Topic AI

Epidermal Langerhans cells are specialized dendritic antigen-presenting cells expressing CD1a, Langerin (CD207), and S100, which contain Birbeck granules mediating receptor-mediated endocytosis of microbial antigens before migrating to draining lymph nodes under CCR7 guidance.

Keratinocytes serve as active immune sensors equipped with toll-like receptors (TLRs 1-9), synthesizing antimicrobial peptides (cathelicidin LL-37, beta-defensins) and releasing epithelial alarmins (IL-1alpha, IL-33, TSLP) that bridge innate tissue stress with adaptive immune activation.

Cutaneous inflammatory diseases are driven by polarized T-helper axes: Th1/IFN-gamma in lichenoid and granulomatous dermatoses; Th2/IL-4/IL-13/IL-31 in atopic eczema and prurigo nodularis; and the IL-23/Th17/IL-17A/IL-22 cascade in psoriasis and neutrophilic dermatoses.

Skin-resident memory T cells (TRM) stably inhabit the epidermis and papillary dermis, characterized by CD69 and CD103 expression; they provide rapid recall pathogen defence but also drive localized, recurrent disease flares in psoriasis plaques, vitiligo, and fixed drug eruptions.

The five foundational cutaneous tissue reaction patterns—spongiotic, psoriasiform, lichenoid/interface, bullous, and granulomatous—form the structural basis of dermatopathology examination slides.

Last updated: September 2026

2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns

Section focus: The immunopathogenesis of inflammatory skin disease: Skin-Associated Lymphoid Tissue (SALT), dendritic cell subsets, cytokine axes (IL-23/Th17 vs Th2/IL-4/IL-13), and the classical histopathological tissue reaction patterns used in clinical and dermatopathology case questions.

1. The Skin Immune System: Cellular Architecture of SALT

The skin is an active immune organ, traditionally termed the Skin-Associated Lymphoid Tissue (SALT) . It integrates physical barrier properties with innate and adaptive immune effector cells across the epidermal and dermal compartments: +=============================================================================+

  • | SKIN IMMUNE SYSTEM ARCHITECTURE |
  • +=============================================================================+
  • | 1. EPIDERMAL COMPARTMENT |
  • | - Keratinocytes: PRRs (TLR1-9), Alarmins (IL-1α, TSLP, IL-33), AMPs |
  • | - Langerhans Cells (LCs): CD1a+, Langerin (CD207)+, Birbeck Granules |
  • | - Epidermal TRM: CD8+ CD69+ CD103+ (resident memory T cells) |
  • +-----------------------------------------------------------------------------+
  • | 2. DERMAL COMPARTMENT |
  • | - Dermal Dendritic Cells (dDCs): CD11c+ cDCs, FXIIIa+ mature dDCs |
  • | - Plasmacytoid Dendritic Cells (pDCs): CD123+, BDCA-2+ (IFN-α producers)|
  • | - Dermal Mast Cells: FcεRI+, CD117+ (c-kit), MRGPRX2+ |
  • | - Innate Lymphoid Cells (ILCs): ILC1 (IFN-γ), ILC2 (IL-13), ILC3 (IL-17)|
  • | - Dermal TRM: CD4+ CD69+ (pathogen sentinel and cytokine producer) |
  • | - Macrophages & Fibroblasts: Phagocytosis, extracellular matrix remodel |
  • +=============================================================================+
  • Langerhans Cells (LCs)

Epidermal Langerhans cells originate from embryonic fetal liver and bone marrow haematopoietic precursors, residing in the mid-stratum spinosum. They constitute approximately 2% to 4% of epidermal cells.

Immunophenotype: Positive for CD45 , HLA-DR , CD1a , Langerin (CD207) , and S100 ; negative for CD83 (immature state).

Ultrastructure: Under transmission electron microscopy, LCs contain pathognomonic Birbeck granules —pentalaminar, rod-shaped or tennis-racket-shaped cytoplasmic organelles containing Langerin. They function in receptor-mediated endocytosis of mannosylated microbial wall antigens (e.g., Candida , HIV-1 gp120).

Migration Dynamics: Upon antigen capture and stimulation by inflammatory alarmins (TNF-alpha, IL-1beta), LCs downregulate E-cadherin (breaking attachment to keratinocytes), upregulate the chemokine receptor CCR7 , and migrate via afferent dermal lymphatics to the paracortex of draining lymph nodes, where they present processed peptides on MHC class II to naive T cells.

Dermal Dendritic Cell Subsets

Classical / Myeloid Dermal DCs (cDCs): CD11c+, CD1c+; efficient at antigen cross-presentation and priming CD4+ T helper cells.

Plasmacytoid Dendritic Cells (pDCs): CD123+, BDCA-2+ (CD303+). Although virtually absent in normal healthy skin, pDCs infiltrate in massive numbers in lupus erythematosus and early eruptive psoriasis . Upon engagement of endosomal TLR7 (ssRNA) and TLR9 (unmethylated CpG DNA), pDCs produce enormous quantities of Type I interferons (IFN-alpha and IFN-beta) , which drive auto-inflammatory cascades.

Factor XIIIa+ Dermal Dendrocytes: Fixed, resident phagocytic dendritic cells in the papillary dermis involved in tissue homeostasis and wound repair.

Resident Memory T Cells (TRM)

Healthy human skin contains an estimated 2 x 10¹⁰ T cells —almost twice the total number circulating in peripheral blood. The vast majority are non-recirculating Resident Memory T Cells (TRM) stably anchored within tissue niches for years:

Surface Phenotype: Characterized by expression of CD69 (which antagonizes the sphingosine-1-phosphate receptor S1P1, preventing chemotactic egress into blood) and CD103 (the alphaE subunit of the alphaEbeta7 integrin, which binds directly to epithelial E-cadherin).

Compartmentalization: CD8+ CD103+ TRM predominantly localize to the epidermis, whereas CD4+ CD69+ CD103- TRM predominate in the papillary dermis.

Clinical Significance: While TRM provide rapid, localized recall protection against recurrent infections (e.g., herpes simplex virus), they also mediate site-specific recurrence in non-infectious dermatoses: the localized, fixed flare-ups of fixed drug eruptions , the recurrence of psoriasis plaques at previously healed sites (forming a lasting "molecular scar"), and the localized autoimmune destruction of melanocytes in stable vitiligo .

Dermal Mast Cells

Located around microvascular loops in the superficial papillary dermis and periadnexal connective tissue. They express the high-affinity receptor for IgE ( Fc-epsilon-RI ) and CD117 (c-kit) .

Activation Triggers: Cross-linking of surface IgE by multivalent allergens; complement anaphylatoxins ( C3a , C5a ); neuropeptides ( substance P ); and direct engagement of the Mas-related G protein-coupled receptor X2 ( MRGPRX2 ) by basic compounds (fluoroquinolones, neuromuscular blocking agents, vancomycin).

Preformed Mediators: Stored within metachromatic granules and extruded within seconds: histamine , tryptase , chymase , heparin , and TNF-alpha .

De Novo Synthesized Mediators: Produced within minutes to hours: leukotrienes ( LTC4 , LTD4 , LTE4 ), prostaglandin D2 ( PGD2 ), platelet-activating factor (PAF), and cytokines ( IL-4 , IL-5 , IL-6 , IL-13 ).

2. Keratinocytes as Active Immune Sentinels

Keratinocytes are not merely structural elements; they act as primary immunological barrier sensors equipped with Pattern Recognition Receptors (PRRs):

Pattern Recognition Receptors (PRRs)

Toll-Like Receptors (TLRs):

Cell Surface TLRs (TLR1, 2, 4, 5, 6): Recognize pathogen-associated molecular patterns (PAMPs) such as bacterial lipopeptides (TLR1/2/6), lipopolysaccharide (TLR4), and flagellin (TLR5).

Endosomal TLRs (TLR3, 7, 8, 9): Detect microbial nucleic acids. TLR3 detects viral dsRNA; TLR7/8 detect viral ssRNA; TLR9 detects unmethylated bacterial/viral CpG DNA motifs.

The NLRP3 Inflammasome: An intracellular protein complex composed of the sensor NLRP3, adapter ASC, and pro-caspase-1. Activated by danger-associated molecular patterns (DAMPs) such as extracellular ATP, uric acid microcrystals, and UV-induced reactive oxygen species. Active caspase-1 cleaves inert precursors into bioactive IL-1beta and IL-18 .

Antimicrobial Peptides (AMPs)

Keratinocytes produce potent endogenous peptide antibiotics that disrupt microbial membranes and recruit immune cells:

Cathelicidin (hCAP18 / LL-37): Stored as inactive hCAP18 and cleaved into the active 37-amino-acid peptide LL-37 by kallikrein serine proteases ( KLK5 and KLK7 ).

In Psoriasis: Overproduced LL-37 complexes with self-DNA and self-RNA released from damaged keratinocytes. These cationic complexes resist nucleases and enter pDCs, triggering endosomal TLR9 (inducing IFN-alpha) and conventional DCs via TLR7/8 , initiating the psoriasis autoimmune loop.

In Rosacea: Excess KLK5 activity produces aberrant, pro-inflammatory LL-37 fragments that induce vascular erythema, telangiectasia, and neutrophilic inflammation.

Human Beta-Defensins (hBD-1, hBD-2, hBD-3): Broad-spectrum antimicrobial peptides active against Gram-negative bacteria ( Pseudomonas ), yeasts, and enveloped viruses. Induced robustly by IL-17A, TNF-alpha, and IL-1beta in psoriasis.

The "Atopic Eczema Vulnerability" Paradigm: In atopic dermatitis , high levels of Th2 cytokines ( IL-4 and IL-13 ) strongly suppress keratinocyte transcription of beta-defensins and cathelicidin. This acquired AMP deficiency explains the intense susceptibility of atopic patients to persistent colonization by Staphylococcus aureus (>90% of patients) and life-threatening dissemination of viral infections ( eczema herpeticum / Kaposi varicelliform eruption via HSV-1, or eczema coxsackium).

Epithelial Alarmins

Upon mechanical damage or chemical irritation, keratinocytes rapidly discharge preformed alarmins :

IL-1alpha: Stored constitutively in basal and suprabasal keratinocytes; triggers immediate neutrophil recruitment.

Thymic Stromal Lymphopoietin (TSLP): Secreted by stressed keratinocytes; acts on dendritic cells to induce an aggressive Th2-polarizing phenotype without inducing IL-12.

IL-33: Nuclear alarmin released during necrotic cell death; binds the ST2 receptor on Th2 cells, ILC2s, and mast cells, accelerating allergic cutaneous inflammation.

3. T-Helper Subsets and Cytokine Cascades in Skin Disease

Cutaneous inflammatory pathology is orchestrated by distinct, cross-regulating CD4+ T helper (Th) cell subsets characterized by specific master transcription factors and signature effector cytokines:

T-Helper Subset Inducing Cytokines (from DCs) Master Transcription Factor Signature Effector Cytokines Cellular Targets & Biological Action Prototypic Cutaneous Diseases Key Therapeutic Biologics / Small Molecules

Th1 IL-12 , IFN-gamma T-bet IFN-gamma , TNF-alpha, IL-2 Activates macrophages; induces CXCL9/10/11 from keratinocytes; recruits CXCR3+ cytotoxic CD8+ T cells Lichen planus , Discoid lupus erythematosus, Vitiligo, Tuberculoid leprosy JAK inhibitors (tofacitinib, baricitinib)

Th2 IL-4 , TSLP, IL-33 GATA3 IL-4 , IL-13 , IL-31 , IL-5 IL-4/13 downregulate filaggrin/involucrin and suppress AMPs; induce B-cell IgE switching; IL-31 directly stimulates neural pruritus via sensory C-fibres; IL-5 activates eosinophils Atopic dermatitis , Prurigo nodularis, Bullous pemphigoid prodrome Dupilumab (anti-IL-4R-alpha), Tralokinumab (anti-IL-13), Nemolizumab (anti-IL-31RA), JAK1 inhibitors (abrocitinib, upadacitinib)

Th17 IL-23 (p19/p40), IL-1beta, IL-6 ROR-gamma-t IL-17A , IL-17F , IL-22 IL-17A/F act on keratinocytes to induce CXCL1/2/8 (neutrophil chemoattractants), CCL20, and AMPs (hBD-2); IL-22 induces acanthosis and inhibits terminal differentiation Psoriasis vulgaris , Generalized pustular psoriasis (GPP), Hidradenitis suppurativa Secukinumab , Ixekizumab (anti-IL-17A); Bimekizumab (anti-IL-17A/F); Guselkumab , Risankizumab (anti-IL-23p19); Ustekinumab (anti-IL-12/23p40)

Th22 IL-6, TNF-alpha AhR (Aryl Hydrocarbon Receptor) IL-22 (without IL-17) Induces marked epidermal hyperplasia, downregulates profilaggrin, synergizes with Th2 cytokines in chronic barrier breakdown Chronic atopic dermatitis, Allergic contact dermatitis Tapinarof (topical AhR agonist modulator)

Treg TGF-beta, IL-2 FoxP3 IL-10 , TGF-beta , CTLA-4 Immunological self-tolerance; suppresses autoreactive effector Th1, Th2, and Th17 responses Defective in autoimmune disease; absent in IPEX syndrome ( FOXP3 mutation: neonatal erythroderma, enteropathy, endocrinopathy) Low-dose IL-2 therapy (investigational) +=============================================================================+

  • | THE PSORIASIS VS ATOPIC ECZEMA IMMUNE PARADIGM |
  • +=============================================================================+
  • | PSORIASIS (IL-23 / Th17 Axis) ATOPIC DERMATITIS (Th2 Axis) |
  • | |
  • | Dermal Dendritic Cell / pDC Keratinocyte Stress / Barrier |
  • | | | |
  • | IL-23 (p19/p40) TSLP, IL-33, IL-25 |
  • | v v |
  • | Th17 / ILC3 Th2 / ILC2 |
  • | | | |
  • | IL-17A, IL-17F, IL-22 IL-4, IL-13, IL-31 |
  • | | | |
  • | +--> Massive AMP synthesis (hBD2, LL-37) +--> SUPPRESSION of AMPs
  • | +--> Neutrophil recruitment (CXCL8) +--> Downregulates FLG/Involucrin
  • | +--> Keratinocyte hyperproliferation +--> Direct sensory nerve itch
  • | v v |
  • | Auspitz sign, silvery scale, sterile pustules Pruritus, S. aureus, weeping eczema
  • +=============================================================================+
  • 4. The Five Foundational Cutaneous Reaction Patterns

Dermatopathology organizes skin diseases into archetypal tissue reaction patterns. Recognizing these patterns on routine haematoxylin and eosin (H&E) staining is central to dermatopathology questions:

1. Spongiotic Reaction Pattern

Histopathological Definition: Spongiosis is intercellular edema within the viable epidermis. Accumulating fluid widens the intercellular spaces between adjacent keratinocytes, stretching the intact desmosomes into prominent, elongated "bridges". In acute phases, intense fluid accumulation ruptures desmosomes, coalescing into intraepidermal spongiotic microvesicles and macrovesicles.

Stages of Spongiotic Dermatitis:

Acute: Marked intercellular edema, intraepidermal vesiculation, exocytosis of lymphocytes and occasional eosinophils into the epidermis, and mild papillary dermal edema.

Subacute: Moderate spongiosis, minimal vesiculation, presence of irregular acanthosis (epidermal thickening), and focal parakeratosis with retention of the granular layer.

Chronic: Minimal or absent spongiosis, prominent regular/irregular acanthosis, hyperkeratosis, hypergranulosis, and dermal fibrosis (collagen bundle realignment) induced by chronic scratching ( lichen simplex chronicus ).

Differential Diagnosis: Allergic contact dermatitis, irritant contact dermatitis, atopic dermatitis, nummular (discoid) eczema, dyshidrotic eczema (pompholyx), and pityriasis rosea.

2. Psoriasiform Reaction Pattern

Histopathological Definition: Epidermal hyperplasia characterized by regular elongation of rete ridges to uniform lengths, resembling "test tubes in a rack" or "wooden palisades".

Key Microscopic Features:

Confluent or patchy parakeratosis with associated hypogranulosis (diminution or absence of the stratum granulosum beneath parakeratotic mounds).

Marked thinning of the suprapapillary epidermal plates (the epidermal tissue bridging adjacent elongated rete ridges).

Tortuous, dilated, congested capillary loops within elongated, edematous dermal papillae (yielding the clinical Auspitz sign upon gentle scraping).

Neutrophilic Infiltration: Pathognomonic collections of neutrophils within the parakeratotic stratum corneum ( Munro microabscesses ) and within degenerate keratinocytes of the upper stratum spinosum ( Spongiform pustules of Kogoj ).

Differential Diagnosis: Psoriasis vulgaris, clear cell acanthoma, secondary syphilis (psoriasiform with numerous plasma cells and interface change), and Pityriasis Rubra Pilaris (PRP) (distinguished by alternating vertical and horizontal orthokeratosis and parakeratosis forming a "checkerboard" pattern , with follicular plugging and preserved granular layer).

3. Lichenoid / Interface Dermatitis Pattern

Histopathological Definition: An inflammatory infiltrate primarily abutting and obscuring the dermo-epidermal junction , associated with hydropic / vacuolar degeneration of basal keratinocytes and individual keratinocyte apoptosis.

Two Primary Morphological Sub-Patterns:

Cell-Rich (Lichenoid) Interface Pattern: Characterized by a dense, band-like ("strip-like") lymphocytic infiltrate hugging the dermal-epidermal junction that obscures the basal lamina.

Classic Prototypic Entity: Lichen Planus .

Diagnostic Triad: Dense band-like lymphocytic infiltrate; apoptotic basal keratinocytes forming round, homogeneous, eosinophilic bodies ( Civatte bodies, colloid bodies, cytoid bodies ); irregular, pointed acanthosis producing a "saw-toothed" rete ridge pattern ; wedge-shaped hypergranulosis ; and compact, orthokeratotic hyperkeratosis (notably lacking parakeratosis ).

Cell-Poor (Vacuolar) Interface Pattern: Characterized by basal layer vacuolization, sparse perivascular lymphocytes, and widely dispersed apoptotic keratinocytes.

Erythema Multiforme: Abundant necrotic keratinocytes distributed throughout multiple levels of the epidermis, accompanied by satellite cell necrosis (lymphocytes directly contacting dying keratinocytes) and subepidermal clefting.

Lupus Erythematosus (CLE / DLE): Basal vacuolization, prominent thickening and hyalinization of the basement membrane (PAS-positive), superficial and deep perivascular and periadnexal lymphocytic infiltration, and abundant interstitial dermal mucin deposition (highlighted by Alcian blue, pH 2.5).

4. Bullous Reaction Pattern

Blistering diseases are classified strictly by the anatomical level of fluid cleavage :

Intraepidermal / Acantholytic Blistering: Characterized by acantholysis —the loss of intercellular cohesion between keratinocytes following desmosomal disruption, causing cells to round up and detach.

Subcorneal Cleavage: Splitting occurs immediately beneath the stratum corneum ( Pemphigus foliaceus , bullous impetigo, SSSS).

Suprabasal Cleavage: Splitting occurs directly above the single basal cell layer, leaving an intact row of basal keratinocytes attached to the basement membrane resembling "a row of tombstones" ( Pemphigus vulgaris , Hailey-Hailey disease, Darier disease, Grover disease).

Subepidermal Blistering: Cleavage occurs beneath the entire viable epidermis, at the level of the dermo-epidermal junction, producing tense blisters whose roof consists of full-thickness epidermis.

With Eosinophils: Bullous Pemphigoid (subepidermal cleft with abundant eosinophils within the blister cavity and lining the dermal-epidermal junction).

With Neutrophils at Papillary Tips: Dermatitis Herpetiformis (microabscesses composed of neutrophils and nuclear dust localized strictly within the tips of dermal papillae, causing micro-clefting; direct immunofluorescence reveals granular IgA deposits in papillary tips).

Pauci-Inflammatory / Cell-Poor: Epidermolysis Bullosa Acquisita (EBA) and Porphyria Cutanea Tarda (PCT) (cell-poor subepidermal separation exhibiting rigid preservation of dermal papillae projecting into the blister cavity, termed "festooning" , with prominent PAS-positive perivascular hyaline cuffs in PCT).

5. Granulomatous Reaction Pattern

Histopathological Definition: A chronic inflammatory pattern characterized by organized, cohesive collections of activated, modified macrophages ( epithelioid histiocytes ), frequently coalescing into multinucleated giant cells .

Four Major Histological Subtypes:

Tuberculoid / Caseating Granulomas: Epithelioid histiocytes surrounding central amorphous, eosinophilic, acellular debris devoid of nuclei ( caseous necrosis ), rimmed by a dense collar of lymphocytes and Langhans-type multinucleated giant cells (nuclei arranged in a peripheral horseshoe ring). Prototypic of cutaneous tuberculosis (lupus vulgaris) and late leishmaniasis.

Sarcoidal / "Naked" Granulomas: Well-circumscribed, compact, rounded islands of epithelioid histiocytes containing multinucleated giant cells, surrounded by a conspicuously sparse or absent rim of lymphocytes ( "naked tubercles" ). Giant cells may display intracellular inclusion bodies: star-shaped asteroid bodies or laminated, basophilic calcifications ( Schaumann bodies ). Pathognomonic of sarcoidosis and berylliosis.

Necrobiotic / Palisaded Granulomas: Granulomatous inflammation arranged in a palisade surrounding central zones of altered, degenerated dermal collagen ( necrobiosis ):

Granuloma Annulare: Incomplete palisades of histiocytes surrounding degenerated collagen and abundant stringy, blue-gray mucin (Alcian blue+); giant cells are sparse; neutrophils are absent.

Necrobiosis Lipoidica: Broad, tiered, horizontal bands of necrobiotic collagen ("lasagna-like" appearance) involving the full thickness of the dermis and extending into subcutaneous septa; prominent infiltrate of plasma cells , vascular endothelial proliferation, and loss of elastic fibers.

Rheumatoid Nodule: Large, sharply demarcated, dense zones of homogeneous, bright pink fibrinoid necrosis surrounded by a prominent palisade of columnar histiocytes, devoid of mucin.

Suppurative / Mixed Granulomas: Epithelioid histiocytes admixed with dense collections of viable and degenerate neutrophils, typically responding to infectious agents (deep fungal infections: blastomycosis, sporotrichosis; atypical mycobacteria: M. marinum ; cat-scratch disease; ruptured follicular cysts). +=============================================================================+

  • | REACTION PATTERN HISTOPATHOLOGY SUMMARY MATRIX |
  • +=============================================================================+
  • | Reaction Pattern | Diagnostic Histological Clue | Prototype Disease |
  • | :--- | :--- | :--- |
  • | **Spongiotic** | Intercellular edema, microvesicles | Allergic contact derm |
  • | **Psoriasiform** | Regular acanthosis, Munro abscess | Psoriasis vulgaris |
  • | **Lichenoid** | Band-like infiltrate, Civatte bodies | Lichen planus |
  • | **Bullous** | Suprabasal tombstoning / subepidermal | Pemphigus / Pemphigoid |
  • | **Granulomatous** | Naked epithelioid tubercles | Cutaneous sarcoidosis |
  • +=============================================================================+